CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 500 target
Drug / intervention
data collectionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06107582
NCT06107582N/ARecruitingOn TrackUpdated 4mo ago
CompareCT.gov

Clinical Characteristics, Prognosis and Prognostic Model of Pediatric Immune Thrombocytopenia: a Prospective, Multicenter, Observational Cohort Study

Institute of Hematology & Blood Diseases Hospital, China·observational·Posted Oct 30, 2023·Updated Feb 11, 2026

In Brief

An observational study evaluating data collection for Primary Immune Thrombocytopenia. Currently recruiting, targeting 500 participants across 1 site.

Detailed Summary

Immune thrombocytopenic purpura (ITP) is a kind of rare childhood disease that involve autoimmune destruction of platelets.The current Pediatric ITP cohorts are mostly based on single-center or multi-center cases, or cohorts with limited sample size in China. There is a lack of comprehensive and large-scale prospective cohort studies in pediatric ITP. The purpose of this study is to analyze the clinical characteristics of Pediatric ITP, the treatment methods, prognosis and prognostic model of these patients in China.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Immune Thrombocytopenia
CountriesChina
CollaboratorsBeijing Children's Hospital, Tianjin People's Hospital, Henan Cancer Hospital, Tianjin Medical University Second Hospital, The First Affiliated Hospital of Xiamen University, The Second Affiliated Hospital of Kunming Medical University

Timeline

N/ARecruiting
20242025202620272028202920302031203220332034203520362037
First PostedOct 30, 2023
Enrollment StartNov 1, 2023
Primary CompletionDec 1, 2026
Study CompletionDec 1, 2036
TodayJul 1, 2026
Enrollment to primary: 3.1 yearsPosted 2.7 years agoPrimary completion in 5 months

Interventions

data collectionother

The study will collect basic information, diagnostic and treatment information from medical records and use questionnaire to measure the exposure of patients, and prospectively follow-up to collect the prognosis information.